These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 4612978)

  • 1. [Antibodies to the autologous tumor cells in tumor induction in mice using methylcholanthrene].
    Vetrova EP; Fedorovskaia MI; Kaminskaia LP; Umanskiĭ IuA
    Vopr Onkol; 1974; 20(3):59-62. PubMed ID: 4612978
    [No Abstract]   [Full Text] [Related]  

  • 2. The formalinization of antibody to tumor cells in altering the immune response.
    Ungaro PC; Drake WP; Mardiney MR
    Cancer Res; 1972 Oct; 32(10):2241-7. PubMed ID: 4117036
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antitumor activity of the lymphocytes of BALB/c and C57BL mice during methylcholanthrene carcinogenesis].
    Umanskiĭ IuA; Semenova-Kobzar' RA; Kushko LIa; Tovmachenko NN
    Vopr Onkol; 1976; 22(6):40-4. PubMed ID: 969342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of non-complement-fixing, blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies.
    Dauphinee MJ; Talal N; Witz IP
    J Immunol; 1974 Sep; 113(3):948-53. PubMed ID: 4413555
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody response to ATPC+ascites tumour in mice rendered resistant by intravenous inoculation of liver cells.
    Pitzurra M; Marconi P
    Boll Ist Sieroter Milan; 1972; 51(5):393-404. PubMed ID: 4656954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies against cells of methylcholanthrene sarcoma in the blood of intact mice].
    Fedorovskaia MI; Vetrova EP; Umanskii IuA
    Biull Eksp Biol Med; 1973 Jul; 76(7):78-80. PubMed ID: 4774443
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of a microassay for the quantitation of cytotoxic antitumor antibody, using 125I-iododeoxyuridine as a target cell label; detection of a static effect on cell DNA synthesis.
    Le Mevel BP; Wells SA
    Biomedicine; 1976 Dec; 24(6):434-42. PubMed ID: 1022316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of the malignancy of tumors in mice induced by 20-methylcholanthrene].
    Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
    Eksp Onkol; 1985; 7(5):21-4. PubMed ID: 4065015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response].
    Spasokukotskiĭ AL
    Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempted induction of tumor antigens in carcinogen-treated cells.
    Outzen HC; Andrews EJ; Basombrío MA; Litwin S; Prehn RT
    J Natl Cancer Inst; 1972 Nov; 49(5):1295-302. PubMed ID: 4568086
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical induction of subcutaneous tumors in BALB-c and Swiss mice infected with wild type C RNA viruses derived from BALB-c tissues.
    Salerno RA; Ramm GM; Whitmire CE
    Cancer Res; 1973 Jan; 33(1):69-77. PubMed ID: 4345153
    [No Abstract]   [Full Text] [Related]  

  • 14. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 15. Different H-2 antigens expressed on two tumors derived from one BALB/c mouse.
    Garrido F; Perez M; Iványi P; Schirrmacher V
    Transplant Proc; 1981 Dec; 13(4):1824-7. PubMed ID: 7330970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD; Hellström I
    J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro sensitization and induction of syngeneic tumor--specific cell--mediated cytotoxicity.
    Ferguson RM; Moe M; Simmons RL
    Surg Forum; 1976; 27(62):117-9. PubMed ID: 1032910
    [No Abstract]   [Full Text] [Related]  

  • 19. [New understanding of immunologic control mechanisms of tumor growth].
    Sjögren HO
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1152-4. PubMed ID: 4341122
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
    Livingston PO; DeLeo AB; Jones M; Oettgen HF
    J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.